JP4959697B2 - アスペルギルス感染のためのin vitro診断法およびキット - Google Patents

アスペルギルス感染のためのin vitro診断法およびキット Download PDF

Info

Publication number
JP4959697B2
JP4959697B2 JP2008520024A JP2008520024A JP4959697B2 JP 4959697 B2 JP4959697 B2 JP 4959697B2 JP 2008520024 A JP2008520024 A JP 2008520024A JP 2008520024 A JP2008520024 A JP 2008520024A JP 4959697 B2 JP4959697 B2 JP 4959697B2
Authority
JP
Japan
Prior art keywords
antigen
aspergillus
antigens
antibody
dppv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008520024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500620A5 (enExample
JP2009500620A (ja
Inventor
アン、ボーベ
ジャン‐ポール、ドゥボピュイ
ジャン‐ポール、ラジェ
ソフィー、パリ
ジャクリーヌ、サルファティ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Pasteur
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Pasteur filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of JP2009500620A publication Critical patent/JP2009500620A/ja
Publication of JP2009500620A5 publication Critical patent/JP2009500620A5/ja
Application granted granted Critical
Publication of JP4959697B2 publication Critical patent/JP4959697B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/38Assays involving biological materials from specific organisms or of a specific nature from fungi from Aspergillus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/908Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008520024A 2005-07-01 2006-06-30 アスペルギルス感染のためのin vitro診断法およびキット Active JP4959697B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05291428A EP1739428A1 (en) 2005-07-01 2005-07-01 In vitro diagnostic method and kit for an aspergillus infection
EP05291428.0 2005-07-01
PCT/IB2006/003039 WO2007015177A2 (en) 2005-07-01 2006-06-30 In vitro diagnostic method and kit for an aspergillus infection

Publications (3)

Publication Number Publication Date
JP2009500620A JP2009500620A (ja) 2009-01-08
JP2009500620A5 JP2009500620A5 (enExample) 2009-07-30
JP4959697B2 true JP4959697B2 (ja) 2012-06-27

Family

ID=35385774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008520024A Active JP4959697B2 (ja) 2005-07-01 2006-06-30 アスペルギルス感染のためのin vitro診断法およびキット

Country Status (8)

Country Link
US (1) US7888041B2 (enExample)
EP (2) EP1739428A1 (enExample)
JP (1) JP4959697B2 (enExample)
AT (1) ATE415629T1 (enExample)
CA (1) CA2613727C (enExample)
DE (1) DE602006003903D1 (enExample)
ES (1) ES2318799T3 (enExample)
WO (1) WO2007015177A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011063395A2 (en) * 2009-11-23 2011-05-26 The Johns Hopkins University Lateral flow device for diagnosing microbial infections
US10585098B2 (en) 2009-11-23 2020-03-10 The Johns Hopkins University Optimizing diagnostics for galactofuranose containing antigens
CN102174485B (zh) * 2011-02-18 2013-07-17 中国人民解放军南京军区南京总医院 一种曲霉免疫优势抗原及用途
US20140178884A1 (en) * 2011-05-23 2014-06-26 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The Univ. Of Nevada, Reno Method of diagnosing and treating an aspergillus species-associated condition
US10107822B2 (en) 2013-12-16 2018-10-23 The Johns Hopkins University Interferon-gamma release assays for diagnosis of invasive fungal infections
CN110954696A (zh) * 2019-11-27 2020-04-03 深圳华瑞达生物科技有限公司 一种曲霉半乳甘露聚糖聚糖检测试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919671D0 (en) * 1989-08-31 1989-10-11 Bush Boake Allen Ltd Biotransformation of fatty substrates
SE9604815D0 (sv) * 1996-12-20 1996-12-20 Pharmacia & Upjohn Ab A metod of diagnosis
JP2002533133A (ja) * 1998-12-23 2002-10-08 ノボザイムス アクティーゼルスカブ アスペルギルス変異体細胞におけるポリペプチドの生産方法
EP1104768B1 (en) * 1999-12-02 2006-11-29 Council of Scientific and Industrial Research Peptide sequences from aspergillus fumigatus for the diagnosis of aspergillosis
JP2002223772A (ja) * 2001-02-01 2002-08-13 Gekkeikan Sake Co Ltd カタラーゼa遺伝子

Also Published As

Publication number Publication date
EP1907853B1 (en) 2008-11-26
WO2007015177A2 (en) 2007-02-08
ATE415629T1 (de) 2008-12-15
DE602006003903D1 (de) 2009-01-08
US20090305312A1 (en) 2009-12-10
JP2009500620A (ja) 2009-01-08
CA2613727A1 (en) 2007-02-08
ES2318799T3 (es) 2009-05-01
EP1739428A1 (en) 2007-01-03
WO2007015177A8 (en) 2007-07-19
WO2007015177A3 (en) 2007-04-12
CA2613727C (en) 2020-07-14
EP1907853A2 (en) 2008-04-09
US7888041B2 (en) 2011-02-15

Similar Documents

Publication Publication Date Title
Sarfati et al. Recombinant antigens as diagnostic markers for aspergillosis
US20110189698A1 (en) Protein Biomarkers and Methods for Diagnosing Kawasaki Disease
CN104374919A (zh) 糖蛋白的测定方法、试剂及糖链标记物
CA2741117A1 (en) Biomarkers for heart failure
SHEN et al. Characterization of allergens from Penicillium oxalicum and P. notatum by immunoblotting and N‐terminal amino acid sequence analysis
WO2024001044A1 (zh) 一种与肺癌相关的生物标志物组合、含其的试剂盒及其用途
JP4959697B2 (ja) アスペルギルス感染のためのin vitro診断法およびキット
EP2612152B1 (en) Method to diagnose infectious peritonitis and predict the severity and outcome thereof in humans.
Delhaes et al. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges
Barrera et al. New commercially available IgG kits and time-resolved fluorometric IgE assay for diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
CN118955706B (zh) 用于检测金黄色葡萄球菌肠毒素a的配对纳米抗体及应用
CN115290902A (zh) 与IgA肾病诊断及预后相关的生物标志物组合物及应用
US20090136973A1 (en) Determination of short-chain srl alcohol dehydrogenase (dhrs4) as a biomarker for inflammations and infections
CA1231047A (en) Diagnostic test for rheumatological diseases
CN114594266B (zh) M1联合m2型巨噬细胞因子作为生物标志物在类风湿关节炎诊断和治疗监测中的用途
CN103954748A (zh) 筛选体外血浆中h7n9生物标记物的方法及其应用
CN115656518A (zh) 一种测定人血浆和尿液中肝素结合蛋白的检测试剂盒
JP7358241B2 (ja) 検出方法及びそのための組成物
EP2223122B1 (en) Endogenous morphine or a naturally occuring metabolite thereof as a marker for sepsis
EP2917730B1 (en) Collagen iv binding assay for the detection of collagen vii
CN118731353A (zh) 鉴别肺腺癌和良性肺部疾病的血浆自身抗体标志物及其应用
CN117007809A (zh) 一种用于诊断细菌性脑膜炎的生物标志物、试剂盒及其应用
Banik Diagnostics of Candida and Candidiasis: Current Methods and Future Perspectives
CN119959549A (zh) 一种用于脓毒症的指示物及其制备方法和应用
CN119780421A (zh) 一种炎症因子标志物crp、saa、pct、il-6四联检验方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090611

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20111020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120224

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120321

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150330

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4959697

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250